Table 3 Lesion and procedure characteristics of the patients.

From: Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease

 

No-restenosis, n = 226

Restenosis, n = 35

P value

Target artery distribution, n (%)

  

0.880

Intra ICA

49(21.68)

8(22.86)

 

MCA

120(53.10)

20(57.14)

 

Intra VA

22(9.73)

2(5.71)

 

BA

35(15.49)

5(14.29)

 

Stenosis degree before intervention, % (IQR)

89.50 (77.58,100.00)

100.00 (83.96,100.00)

0.011

Total occlusion, n (%)

83 (36.73%)

21 (60.00%)

0.009

Median lesion length, mm (IQR)

5.58(3.57,8.46)

10.92(5.70,13.49)

< 0.001

Dissection after PCB dilation

13(5.75%)

2(5.71%)

1.000

Residual stenosis after intervention, % (IQR)

21.35(0.00,32.39)

38.11(26.45,48.39)

< 0.001

Stenting, n (%)

107(47.35)

9(25.71)

0.017

  1. Values are mean ± SD or median (interquartile range), or n (%). Intra ICA, intracranial internal carotid artery, MCA, middle cerebral artery, Intra VA, intracranial vertebral artery, or BA, basilar artery.
Back to article page